Aims Therapeutic drug monitoring of infliximab can guide clinical decisions in patients with
loss of response and in those who can benefit from a de‐intensification. The aim of this study …

We read with great interest the paper by Pérez-Pitarch et al. entitled “A pharmacokinetic
approach to model-guided design of infliximab schedules in ulcerative colitis patients”(1) …

La esclerosis multiple (EM) es la enfermedad autoinmune, inflamatoria, cronica y
degenerativa mas prevalente a nivel mundial, cuya forma mas frecuente es la EM remitente …

Different scientific societies have frequently revised the recommendations for the treatment
of anaemia in patients with pre-dialysis (no-D) chronic kidney disease (CKD), which include …

Background Digoxin, the oldest cardiovascular drug, has been used for the treatment of
heart failure and in frequency control strategies in atrial fibrillation (AF) patients. American …

[Individualized infliximab therapy: pharmacokinetic monitoring]. - Abstract - Europe PMC Sign
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

PP008-SUN: Predictive Factors of Parenteral Nutrition Hyperglycemic Events in Non-Intensive
Care Unit Patients × Close The Infona portal uses cookies, ie strings of text saved by a …

Los anticuerpos monoclonales (mAb) representan uno de los grupos terapéuticos de mayor
interés en el desarrollo farmacológico. Por toda su complejidad (estructural y funcional), el …

La dermatitis atópica (DA) es una enfermedad multifactorial, crónica, pruriginosa e
inflamatoria de la piel. El estudio de su fisiopatología ha permitido el desarrollo de fármacos …

Hemos leído con interés el artículo publicado en su revista por Elberdín L et al titulado La
monitorización farmacocinética como nueva herramienta para individualizar la terapia anti …